The Board of Directors governs the Neuroendocrine Tumor Research Foundation’s strategic, scientific, and financial direction. The Board of Directors comprises highly-distinguished community leaders who share a commitment to discovering a cure for neuroendocrine cancer. All members of the Board of Directors are dedicated to achieving the NET Research Foundation’s mission, supporting the neuroendocrine cancer community through education, and maintaining transparency and accountability.
Review our most recent annual report.
Emeritus members are Directors who have made a significant impact on NETRF, have completed their Board service and continue to support NETRF’s mission.
- Nicholas Vantzelfde
- James Panagis, MD
- Carol Branaman